Kathryn A Barr is a notable inventor based in Bartlesville, OK (US). She has made significant contributions to the field of biotechnology, particularly in the production of Bacillus entomotoxins and human serum albumin. With a total of 3 patents, her work has implications for both agriculture and medicine.

Latest Patents

One of her latest patents focuses on the "Production of Bacillus entomotoxins in methylotrophic yeast." This invention provides a method for producing Bacillus toxin polypeptides by culturing methylotrophic yeast cells that express the necessary genes. The preferred species for this process is Pichia pastoris, which allows for high-level expression of the toxin polypeptides. These transformed yeast cells can be used as an insecticidal composition to target susceptible insect larvae.

Another significant patent by Barr is related to the "Expression of human serum albumin in Pichia pastoris." This invention involves expression cassettes that include a regulatory region from various Pichia pastoris genes, operably linked to a human serum albumin (HSA) structural gene. The invention outlines methods for the secretion of HSA using these expression cassettes, which can be crucial for therapeutic applications.

Career Highlights

Throughout her career, Kathryn A Barr has worked with reputable organizations such as Research Corporation Technologies, Inc. and Phillips Petroleum Company. Her experience in these companies has contributed to her expertise in biotechnology and patent development.

Collaborations

Some of her notable coworkers include Gregory P Thill and Michael Miller Harpold. Their collaboration has likely enhanced the innovative processes and research outcomes in which Barr has been involved.

Conclusion

Kathryn A Barr's contributions to biotechnology through her patents demonstrate her innovative spirit and dedication to advancing scientific knowledge. Her work continues to impact both agricultural and medical fields significantly.